Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
about
First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studiesFifty years of melphalan use in hematopoietic stem cell transplantationComparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trialsSalvage second hematopoietic cell transplantation in myelomaBortezomib salvage followed by a Phase I/II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myelomaDurable remission with salvage second autotransplants in patients with multiple myeloma.How we manage autologous stem cell transplantation for patients with multiple myelomaEvolution of treatment regimens in multiple myeloma: a social network analysisInternational Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myelomaGuidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies.International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).Environmental-mediated drug resistance: a target for multiple myeloma therapy.Guidelines for the diagnosis and management of multiple myeloma 2011.International Myeloma Working Group recommendations for global myeloma care.The impact of intra-clonal heterogeneity on the treatment of multiple myeloma.Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.The role of tandem stem cell transplantation for multiple myeloma patients.Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting).Current Review on High-Risk Multiple Myeloma.Management of Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma.Multiple myeloma: an update.Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial.Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF.Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant-A Prospective Phase II StudyRe: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.The evolution of stem-cell transplantation in multiple myeloma.Multiple myeloma
P2860
Q24197999-4C4AB75A-9BCC-4CBD-B552-17F311D034A0Q26824498-B778E0F9-0849-4B2D-B0A7-1E01FCE98437Q27024932-494B8DED-01A2-4DB1-B7FA-F1ADC2E744DEQ30416452-29D38B25-921A-4E9A-A24D-FA428FA92A3CQ33648344-C046B1CF-AAED-4D93-A3F6-791040B8E7BAQ33685400-A6CB82B4-587B-48DA-98F3-1DDB6A0EF73EQ34019581-786AD360-9AAD-4C3A-8899-1B5A89416527Q35224015-A3A6E58D-6F85-4F89-A7CB-B1C66C32D272Q35802414-3576B2F4-21DB-4BED-B1DF-FBE56C39DE62Q36148528-A3377EC0-3647-4E38-A379-6394F7944480Q37057028-5EB9E5D0-AEBC-444B-89B2-FDB0965EE208Q37370051-98456ADE-1D94-4277-BC66-26C39BD61689Q37530452-365D21BF-159E-4598-B01A-006E8684FB1BQ37810085-D729E3D1-6464-4AD9-A4DB-A0E99CDBF67AQ37875193-93E91605-20A0-4D51-9A88-49B9940AD2EDQ38157532-56C5EBC2-BB10-423A-A214-FB867201EE00Q38192044-1DE77D1B-F386-479D-8D97-95A56B1ADEB3Q38316150-E8A1205E-C624-4040-AB1E-4FE6368F3217Q38677358-CEA9C148-BFE0-459A-8923-2B4B63A1C1B9Q38688055-0F25D935-BA35-4778-9D27-560CBEA4F826Q38895167-EC25AE3E-6031-4196-AC83-A157672794C0Q38970595-180A6E9F-A115-4D65-B624-0A2D0EF2E937Q39471739-035DC5E1-1F83-4F8D-B7CE-B4C6DF5B2B07Q40845932-B04F2FDA-4A42-4606-A4F9-68D25A8CAAB3Q41274044-7892991D-503A-43F3-94F1-D93965B7F11DQ41901542-819E758B-C3FC-44EC-92DC-EA30617CE9C3Q42580823-A74086C2-DF8D-4378-9FF8-06AF0CB63842Q52715329-570E5EF0-2A54-4C64-B9DC-61DA3949FB27Q56657250-C1CB77E3-ABF1-4037-9BE8-02ADABFBA8AB
P2860
Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tandem versus single autologou ...... atic review and meta-analysis.
@en
Tandem versus single autologou ...... atic review and meta-analysis.
@nl
type
label
Tandem versus single autologou ...... atic review and meta-analysis.
@en
Tandem versus single autologou ...... atic review and meta-analysis.
@nl
prefLabel
Tandem versus single autologou ...... atic review and meta-analysis.
@en
Tandem versus single autologou ...... atic review and meta-analysis.
@nl
P2093
P2860
P356
P1476
Tandem versus single autologou ...... atic review and meta-analysis.
@en
P2093
Ambuj Kumar
Axel Glasmacher
Mohamed A Kharfan-Dabaja
P2860
P304
P356
10.1093/JNCI/DJN439
P407
P577
2009-01-13T00:00:00Z